BioGaia AB (publ)

BATS-CHIXE:BIOGBs Stock Report

Market Cap: SEK 10.1b

BioGaia Future Growth

Future criteria checks 2/6

BioGaia is forecast to grow earnings and revenue by 3.4% and 10.5% per annum respectively while EPS is expected to grow by 3.3% per annum.

Key information

3.4%

Earnings growth rate

3.3%

EPS growth rate

Biotechs earnings growth37.0%
Revenue growth rate10.5%
Future return on equityn/a
Analyst coverage

Low

Last updated14 Nov 2023

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BATS-CHIXE:BIOGBs - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20251,593438N/AN/A1
12/31/20241,436397N/AN/A1
12/31/20231,281356N/AN/A1
9/30/20231,273437361396N/A
6/30/20231,213415311342N/A
3/31/20231,186413310324N/A
12/31/20221,104374301319N/A
9/30/20221,036273262284N/A
6/30/2022952246286305N/A
3/31/2022867222263273N/A
12/31/2021785196215222N/A
9/30/2021767196215220N/A
6/30/2021725164201208N/A
3/31/2021766188177190N/A
12/31/2020747180205221N/A
9/30/2020767194155184N/A
6/30/2020802211155189N/A
3/31/2020780193147185N/A
12/31/2019768187109148N/A
9/30/2019770192133160N/A
6/30/2019778205152174N/A
3/31/2019756207161176N/A
12/31/2018742215170183N/A
9/30/2018702206211223N/A
6/30/2018675197176192N/A
3/31/2018631181158181N/A
12/31/2017615181196223N/A
9/30/2017584179174201N/A
6/30/2017562172N/A210N/A
3/31/2017542163N/A198N/A
12/31/2016535160N/A148N/A
9/30/2016500138N/A115N/A
6/30/2016480129N/A86N/A
3/31/2016478130N/A108N/A
12/31/2015483138N/A118N/A
9/30/2015500130N/A100N/A
6/30/2015474119N/A67N/A
3/31/201543297N/A55N/A
12/31/2014482147N/A124N/A
9/30/2014451146N/A126N/A
6/30/2014433145N/A163N/A
3/31/2014426142N/A167N/A
12/31/201331662N/A78N/A
9/30/201329860N/A57N/A
6/30/201329961N/A25N/A
3/31/201328961N/A-9N/A
12/31/2012645327N/A336N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BIOGBs's forecast earnings growth (3.4% per year) is above the savings rate (1.5%).

Earnings vs Market: BIOGBs's earnings (3.4% per year) are forecast to grow slower than the UK market (10.3% per year).

High Growth Earnings: BIOGBs's earnings are forecast to grow, but not significantly.

Revenue vs Market: BIOGBs's revenue (10.5% per year) is forecast to grow faster than the UK market (4% per year).

High Growth Revenue: BIOGBs's revenue (10.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if BIOGBs's Return on Equity is forecast to be high in 3 years time


Discover growth companies